Rhenman & Partners Asset Management AB
Filing Date
Global Rank
#1,893
/ 8,700
▲ 771
Top Industry
Biotechnology
31.6%
Period ended 2 months ago
Filed Aug 13, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
99 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
3.7%
−1.3 pts
Top 5
14.2%
−5.7 pts
Top 10
25.1%
−7.8 pts
HHI
153
Diversified−47
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,059,676,215 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | +370,750 | 684,250 | $16,599,905 | |
| KURA | Kura Oncology, Inc. | +320,000 | 591,500 | $6,488,755 | |
| RLAY | Relay Therapeutics, Inc. | +206,000 | 566,000 | $10,589,860 | |
| SNDX | Syndax Pharmaceuticals Inc | +181,000 | 560,250 | $12,247,065 | |
| MLYS | Mineralys Therapeutics, Inc. | +153,300 | 416,371 | $11,233,689 | |
| MLTX | MoonLake Immunotherapeutics | +145,300 | 384,800 | $7,492,056 | |
| BTSG | BrightSpring Health Services, Inc. | +115,896 | 165,896 | $11,569,587 | |
| AVR | Anteris Technologies Global Corp. | +100,000 | 1,538,625 | $15,155,456 | |
| EW | Edwards Lifesciences Corp | +97,000 | 260,000 | $23,519,600 | |
| PNTG | Pennant Group, Inc. | +96,072 | 371,471 | $13,725,853 | |
| IDYA | IDEAYA Biosciences, Inc. | +88,300 | 343,800 | $12,813,426 | |
| BMRN | Biomarin Pharmaceutical Inc | +83,500 | 290,500 | $16,622,410 | |
| NKTR | Nektar Therapeutics | +82,250 | 141,250 | $9,860,662 | |
| DHR | Danaher Corp /De/ | +62,200 | 80,252 | $15,286,400 | |
| ALGN | Align Technology Inc | +55,500 | 63,000 | $10,625,580 | |
| MDT | Medtronic plc | +55,000 | 145,000 | $11,343,350 | |
| ALKS | Alkermes plc. | +52,000 | 185,250 | $9,707,100 | |
| A | Agilent Technologies, Inc. | +50,000 | 75,000 | $9,962,250 | |
| UNH | Unitedhealth Group Inc | +48,100 | 93,600 | $38,902,968 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +46,600 | 139,205 | $16,296,729 | |
| GKOS | GLAUKOS Corp | +35,000 | 119,000 | $16,631,440 | |
| STVN | Stevanato Group S.p.A. | +31,296 | 305,972 | $5,528,914 | |
| THC | Tenet Healthcare Corp | +31,200 | 85,200 | $15,939,216 | |
| CRL | Charles River Laboratories International, Inc. | +31,200 | 57,200 | $12,972,388 | |
| PODD | Insulet Corp | +28,000 | 42,000 | $6,394,500 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | −350,000 | 1,705,327 | $7,094,160 | |
| OSCR | Oscar Health, Inc. | −268,000 | 392,000 | $11,179,840 | |
| BSX | Boston Scientific Corp | −174,500 | 450,500 | $19,227,340 | |
| WAY | Waystar Holding Corp. | −164,000 | 178,566 | $3,665,959 | |
| PRCT | PROCEPT BioRobotics Corp | −130,000 | 345,000 | $7,790,100 | |
| DOCS | Doximity, Inc. | −107,701 | 76,107 | $1,578,459 | |
| OCUL | Ocular Therapeutix, Inc | −80,000 | 225,000 | $2,209,500 | |
| VEEV | Veeva Systems Inc | −68,000 | 17,300 | $3,070,231 | |
| CVS | CVS HEALTH Corp | −57,126 | 279,374 | $28,901,240 | |
| ALHC | Alignment Healthcare, Inc. | −56,367 | 997,083 | $23,740,546 | |
| RPRX | Royalty Pharma plc | −36,000 | 197,000 | $11,045,790 | |
| IONS | Ionis Pharmaceuticals Inc | −33,000 | 59,900 | $4,749,471 | |
| VKTX | Viking Therapeutics, Inc. | −32,000 | 128,000 | $4,993,280 | |
| GH | Guardant Health, Inc. | −30,000 | 115,000 | $17,253,450 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −20,710 | 27,390 | $17,078,760 | |
| DNLI | Denali Therapeutics Inc. | −20,000 | 179,000 | $4,603,880 | |
| STOK | Stoke Therapeutics, Inc. | −18,500 | 64,500 | $2,110,440 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −17,265 | 17,200 | $5,177,716 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −16,500 | 128,000 | $10,433,280 | |
| ABT | Abbott Laboratories | −16,000 | 96,000 | $8,711,040 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | −16,000 | 8,050 | $4,322,447 | |
| NBIX | Neurocrine Biosciences Inc | −15,000 | 85,841 | $14,467,642 | |
| BIIB | Biogen Inc. | −14,250 | 94,850 | $20,493,291 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −12,800 | 30,685 | $15,242,160 | |
| LLY | ELI LILLY & Co | −11,400 | 22,315 | $26,765,282 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 151,500 | $28,727,430 | |
| MRK | Merck & Co., Inc. | 213,500 | $27,434,750 | |
| JNJ | Johnson & Johnson | 72,500 | $18,412,825 | |
| CNC | Centene Corp | 244,000 | $15,662,360 | |
| DXCM | Dexcom Inc | 160,000 | $10,776,000 | |
| SYRE | Spyre Therapeutics, Inc. | 119,300 | $10,591,454 | |
| ORKA | Oruka Therapeutics, Inc. | 80,000 | $7,613,600 | |
| ERAS | Erasca, Inc. | 349,000 | $6,393,680 | |
| ASTH | Astrana Health, Inc. | 118,888 | $5,517,592 | |
| MOH | Molina Healthcare, Inc. | 21,857 | $4,998,695 | |
| AMN | Amn Healthcare Services Inc | 144,466 | $4,676,364 | |
| MEDP | Medpace Holdings, Inc. | 8,500 | $4,501,515 | |
| MBX | MBX Biosciences, Inc. | 62,000 | $3,422,400 | |
| BCAX | Bicara Therapeutics Inc. | 88,150 | $2,617,173 | |
| PRVA | Privia Health Group, Inc. | 50,000 | $1,286,500 | |
| MMED | MiniMed Group, Inc. | 55,000 | $822,250 | |
| AGL | agilon health, inc. | 5,000 | $535,900 | |
| TXG | 10x Genomics, Inc. | 8,500 | $325,890 | |
| TNDM | Tandem Diabetes Care Inc | 20,000 | $301,800 | |
| TGTX | Tg Therapeutics, Inc. | 5,000 | $274,700 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IQV | Iqvia Holdings Inc. | 53,000 | $9,038,620 | |
| APGE | Apogee Therapeutics, Inc. | 75,000 | $6,312,750 | |
| IMCR | Immunocore Holdings plc | 85,724 | $2,584,578 | |
| CMPX | Compass Therapeutics, Inc. | 115,113 | $608,947 | |
| ADPT | Adaptive Biotechnologies Corp | 720,000 | $0 | |
| — | 985,000 | $0 | ||
| — | 81,200 | $0 | ||
| No positions match the current search. | ||||
99 tracked positions ·
$1,059,676,215 total
· filing declares
99 positions · $1,059,428,235
· as of Jun 30, 2026
Showing 1–50
of 99 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 93,600 | $38,902,968 | 3.67% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 279,374 | $28,901,240 | 2.73% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 151,500 | $28,727,430 | 2.71% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 213,500 | $27,434,750 | 2.59% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 22,315 | $26,765,282 | 2.53% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Added | 96,775 | $24,352,461 | 2.30% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Reduced | 997,083 | $23,740,546 | 2.24% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 260,000 | $23,519,600 | 2.22% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 178,250 | $22,520,105 | 2.13% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Added | 87,440 | $21,070,416 | 1.99% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 94,850 | $20,493,291 | 1.93% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 65,000 | $20,464,600 | 1.93% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 450,500 | $19,227,340 | 1.81% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 72,500 | $18,412,825 | 1.74% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 115,000 | $17,253,450 | 1.63% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 27,390 | $17,078,760 | 1.61% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Added | 119,000 | $16,631,440 | 1.57% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 290,500 | $16,622,410 | 1.57% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 684,250 | $16,599,905 | 1.57% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 61,050 | $16,572,022 | 1.56% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 139,205 | $16,296,729 | 1.54% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 151,960 | $16,201,975 | 1.53% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Added | 85,200 | $15,939,216 | 1.50% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 31,580 | $15,832,948 | 1.49% | |
| CNC |
Centene Corp
Healthcare
|
NEW | 244,000 | $15,662,360 | 1.48% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 63,050 | $15,432,748 | 1.46% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 80,252 | $15,286,400 | 1.44% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 30,685 | $15,242,160 | 1.44% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 1,538,625 | $15,155,456 | 1.43% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 85,841 | $14,467,642 | 1.37% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
Added | 371,471 | $13,725,853 | 1.30% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 34,500 | $13,719,960 | 1.29% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 34,900 | $13,496,877 | 1.27% | |
| LIVN |
LivaNova PLC
Healthcare
|
Added | 164,000 | $13,485,720 | 1.27% | |
| COR |
Cencora, Inc.
Healthcare
|
Reduced | 46,778 | $13,237,238 | 1.25% | |
| CRL |
Charles River Laboratories International, Inc.
Healthcare
|
Added | 57,200 | $12,972,388 | 1.22% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 343,800 | $12,813,426 | 1.21% | |
| MCK |
Mckesson Corp
Healthcare
|
Reduced | 16,550 | $12,505,180 | 1.18% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 560,250 | $12,247,065 | 1.16% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 165,896 | $11,569,587 | 1.09% | |
| MDT |
Medtronic plc
Healthcare
|
Added | 145,000 | $11,343,350 | 1.07% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 416,371 | $11,233,689 | 1.06% | |
| OSCR |
Oscar Health, Inc.
Healthcare
|
Reduced | 392,000 | $11,179,840 | 1.06% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Reduced | 197,000 | $11,045,790 | 1.04% | |
| DXCM |
Dexcom Inc
Healthcare
|
NEW | 160,000 | $10,776,000 | 1.02% | |
| ALGN |
Align Technology Inc
Healthcare
|
Added | 63,000 | $10,625,580 | 1.00% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 119,300 | $10,591,454 | 1.00% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 566,000 | $10,589,860 | 1.00% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 128,000 | $10,433,280 | 0.98% | |
| A |
Agilent Technologies, Inc.
Healthcare
|
Added | 75,000 | $9,962,250 | 0.94% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.